These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31532266)

  • 1. Neprilysin, the kidney brush border neutral proteinase: a possible potential target for ischemic renal injury.
    Sankhe R; Kinra M; Mudgal J; Arora D; Nampoothiri M
    Toxicol Mech Methods; 2020 Feb; 30(2):88-99. PubMed ID: 31532266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Role of Neprilysin in Kidney Angiotensin Metabolism.
    Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Berlakovich G; Kain R; Stegbauer J; Rahman M; Hellinger R; Gruber C; Grobe N; Fajkovic H; Eskandary F; Böhmig GA; Säemann MD; Kovarik JJ
    Circ Res; 2020 Aug; 127(5):593-606. PubMed ID: 32418507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.
    Domenig O; Manzel A; Grobe N; Königshausen E; Kaltenecker CC; Kovarik JJ; Stegbauer J; Gurley SB; van Oyen D; Antlanger M; Bader M; Motta-Santos D; Santos RA; Elased KM; Säemann MD; Linker RA; Poglitsch M
    Sci Rep; 2016 Sep; 6():33678. PubMed ID: 27649628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrarenal Mas and AT
    O'Neill J; Healy V; Johns EJ
    Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
    Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC
    Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
    Ali Q; Dhande I; Samuel P; Hussain T
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Progress and Knowledge Basis on the Natriuretic Peptide System in Heart Failure.
    Fu S; Chang Z; Luo L; Deng J
    Curr Top Med Chem; 2019; 19(20):1850-1866. PubMed ID: 31448711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current role of neprilysin inhibitors in hypertension and heart failure.
    von Lueder TG; Atar D; Krum H
    Pharmacol Ther; 2014 Oct; 144(1):41-9. PubMed ID: 24836726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease.
    Chen Y; Burnett JC
    Clin Chem; 2017 Jan; 63(1):108-115. PubMed ID: 28062615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure.
    Margulies KB; Perrella MA; McKinley LJ; Burnett JC
    J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down regulation of kidney neutral endopeptidase mRNA, protein and activity during acute renal failure: possible mechanism for ischemia-induced acute renal failure in rats?
    Nambi P; Pullen M; Wu HL; Prabhakar U; Hersh L; Gellai M
    Mol Cell Biochem; 1999 Jul; 197(1-2):53-9. PubMed ID: 10485324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
    Santos RA; Ferreira AJ; Verano-Braga T; Bader M
    J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and regulation of the angiotensin-converting enzyme type 2/angiotensin-(1-7)/MAS receptor axis during the ovulation process in cattle.
    Tonellotto dos Santos J; Ferreira R; Gasperin BG; Siqueira LC; de Oliveira JF; Santos RA; Reis AM; Gonçalves PB
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):91-8. PubMed ID: 21824993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretory responses to renal nerve stimulation during inhibition of neutral metalloendopeptidase and angiotensin-converting enzyme in the rat.
    Golin R; Protasoni G; Wjinmaalen P; Sala C; Monopoli A; Casati C; Zanchetti A; Stella A
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):665-71. PubMed ID: 8945680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
    J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.
    Brignone J; Assersen KB; Jensen M; Jensen BL; Kloster B; Jønler M; Lund L
    Pflugers Arch; 2021 Apr; 473(4):595-610. PubMed ID: 33844072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats.
    da Silveira KD; Pompermayer Bosco KS; Diniz LR; Carmona AK; Cassali GD; Bruna-Romero O; de Sousa LP; Teixeira MM; Santos RA; Simões e Silva AC; Ribeiro Vieira MA
    Clin Sci (Lond); 2010 Jul; 119(9):385-94. PubMed ID: 20528771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.
    Burrell LM; Farina N; Risvanis J; Woollard D; Casely D; Johnston CI
    Clin Sci (Lond); 1997 Jul; 93(1):43-50. PubMed ID: 9279202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
    Rodrigues Prestes TR; Rocha NP; Miranda AS; Teixeira AL; Simoes-E-Silva AC
    Curr Drug Targets; 2017; 18(11):1301-1313. PubMed ID: 27469342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.